Zyga Enrolls 1st Patient in SImmetry SI Joint Fusion Study: 5 Observations

Zyga Technology announced the first patient enrollment in its study to evaluate fusion and pain reduction following use of the SImmetry Sacroiliac Joint Fusion System.

Here are five things to know:

1. The SImmetry Sacroiliac Joint Fusion System is a minimally invasive procedure intended for conditions such as sacroiliac joint disruptions and degenerative sacroiliitis. It was granted 510(k) clearance by the U.S. Food and Drug Administration in March 2013.

2. The prospective, single-arm, post-market study, called the Sacroiliac Fusion Study or SAIF, will be performed at a single center and will include up to 15 patients. “Clinical studies such as SAIF are critical to demonstrate the empirical value of sacroiliac joint fusion,” said Noel D. Goldthwaite, MD, who performed the surgery for the study.



Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button